Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast

scientific article published on 01 July 1990

Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2170971

P2093author name stringMaguire HC Jr
Weiner DB
Greene MI
Lodato RF
LiVolsi VA
P433issue4
P921main subjectimmunohistochemistryQ899285
Atypical ductal hyperplasiaQ4818889
ductal carcinomaQ5311598
P304page(s)449-454
P577publication date1990-07-01
P1433published inModern PathologyQ15724578
P1476titleImmunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast
P478volume3

Reverse relations

cites work (P2860)
Q37265571Apocrine adenosis: a precursor of aggressive breast cancer?
Q35671149Biological features of premalignant disease in the human breast
Q40848953Biological indices in the assessment of breast cancer
Q40684734Current management of carcinoma of the breast
Q33642507Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes
Q92015590Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers
Q89879114HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies
Q26780318HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
Q91728336HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Q35775640Identification of genes expressed in premalignant breast disease by microscopy-directed cloning
Q41710798Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors
Q71989512MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo
Q35782037Molecular analysis of premalignant and carcinoma in situ lesions of the human breast
Q28363615Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53
Q37020386Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood
Q41659124Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component
Q35096055Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma
Q36434480The enigmatic nature of apocrine breast lesions
Q37326072The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
Q38673589When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase
Q37119722c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

Search more.